Impact case study: HIV prevention in Australia
Through community and government partnerships, Kirby Institute research demonstrated that targeted, at-scale, rapid implementation of PrEP quickly reduces new HIV infections. This research provided an evidence base to inspire other countries to roll out PrEP quickly and at scale.
Impact case study: Hep C treatment for marginalised populations
Through world-leading clinical research, the Kirby Institute at UNSW Sydney was the first in Australia and among the first globally to show that hepatitis C treatment was safe and feasible in people who were currently injecting drugs.